, and GIDSEEN Group Ã Purpose of review To describe the experience in Spain concerning the public healthcare for transsexual persons using a multidisciplinary approach and to review the relevant literature. Treatment includes social and psychological support, cross-hormone treatment, and sex reassignment surgeries. Although the recommendations of The World Professional Association for Transgender Health are used as guidelines, the application of these standards of care varies considerably, probably because of specific clinical and country factors.
INTRODUCTION
The care of transsexual people under the public health service in Spain is recent, the therapeutic approach has similarities and differences with other international units. The sex reassignment process (SRP) was first approved in 1999 in Andalusia (southern region), since when the Andalusian Gender Team (AGT) has become a reference gender identity unit (GIU) for a much larger area. Changes in the law and the opening of other multidisciplinary units have resulted in Spain becoming an advanced nation in the legislation for and provision of public health for transsexuality [1, 2, 3 && , [4] [5] [6] . In 2002, other units started functioning (Catalonia, Madrid), and since 2007, there have been nine GIUs in Spain. Four of these offer integral treatment, another two include mastectomies and hystero-oophorectomies but not genitoplasties, and the remaining three just provide a psychological diagnosis and cross-hormone therapy [7] [8] [9] 10 & ]. More than 4000 people with gender dysphoria have now been treated in Spain, as seen in the article by Esteva de Antonio et al. [10 & ]. This study, though, shows that the geographic distribution is not homogeneous and close to the patients, as in other European countries [3 && ,5] . All the GIUs in Spain comprise multidisciplinary teams which, working in groups, have agreed protocols about the SRP [11 & ]. Some of the older units have already published their experience and clinical outcomes [5, 9, [12] [13] [14] [15] [16] [17] .
In 2007, the Spanish government approved a law authorizing a change in name and sex at the registry office for transsexual persons aged over 18 years, provided they had a medical diagnosis report and had been receiving supervised crosshormone therapy for at least 2 years [18] . This decision has meant a great advance for their psychosocial adjustment, eliminating the requirement for genital surgery or gonadectomy that other countries still require [3 && ,19-23] .
METHODOLOGY AND OBJECTIVES OF A MULTIDISCIPLINARY TEAM
No discipline offers just one single method of approaching knowledge, there are always many. One way of dealing with complexity is with multidisciplinary teams and with different paradigms and methods. Gender dysphoria is an example of complexity, particularly in recent years. Transsexualism is the most extreme form of gender dysphoria and that which can most benefit from integral treatment: diagnosis and psychological support, crosssex hormone treatment, and sex reassignment surgeries (therapeutic triad). Professionals who work in GIUs recognize that times are changing in the terminology of the diverse clinical situations seen, the attitude of the individuals with gender conflicts, the demands on the health system, and the age of the applicants [ . These teams must guarantee scientific competence and ethical consistency. They must maintain a transverse structure among their members and use a common language to identify the therapeutic needs of transsexual people and address other situations of transgenderism or gender variants, not amenable to treatment in the health field, but involving anthropological or sociological approaches.
During these early years of functioning, the main objective of GIUs in Spain has been to create a disciplinary space and dignify the attendance given to the transsexuals. This has not been easy because these units have had to face prejudice and misinformation by society [33, 34] .
MULTIDISCIPLINARY EXPERIENCE IN THE ANDALUSIAN GENDER TEAM
The following lines describe the experience of our multidisciplinary team, which reflects the care model now incorporated in the Spanish public health system for transsexual people. The AGT was formed in 1999 as a result of coordination between different specialists, primarily psychiatrist and psychologist, endocrinologist, plastic surgeons and gynecologists at Carlos Haya University Hospital, in Malaga, Spain. This unit has now treated over 1400 persons. On average, 80 adults apply for sex reassignment each year and there have been a total of 141 children and adolescents with gender dysphoria referred to us in this period.
The characteristics and status of the population seen by the AGT are shown in Table 1 . The diagnosis was confirmed in 90% of those seen. During the first few years, the percentage of cases excluded from the SRP exceeded 15%, probably because of the historical population of individuals with different identity conflicts and no criteria enabling the SRP. About 25% of individuals abandon the process during the early stages. Our drop-out figures, as with those of other units [3 && ], could be explained because the procedures in the public health service involve stricter protocols and longer evaluation periods [3 && ,20] . In the AGT, more than one-third of the male-to-female transsexuals (MtFs) have already undergone female genitoplasty and over 60% of the female-to-male transsexuals (FtMs) have undergone various types of sex reassignment surgeries during the follow-up.
Patient information on the sex reassignment process
The patients participate in the therapeutic process and decision-making after being adequately informed by the team about the procedures and waiting times for the SRP. The coordination of this assistance also implies permanent negotiation with the patients concerning their urgent expectations.
The AGT procedures are adapted from the international guidelines for gender dysphoria [1,2,3 && ,4,35,36] . Upon the first request to the AGT, the patient receives two appointments: one for the psychologist and one for the endocrinologist. Thus begins the diagnostic evaluation not only of the gender dysphoria, but also the basal clinical situation. At this stage, the patient signs the first
KEY POINTS
Transsexualism and the current gender variants are complex clinical situations that require coordination between different professionals in a team.
The growing demand of children and adolescents with gender dysphoria involves working with families and social associations too.
The sex reassignment should be considered a public health right and it is important to evaluate the quality of care and outcomes of this process.
informed consent with the psychologist for authorizing the psychological evaluation process, including successive semi-structured interviews and psychological tests [1,2,3 && ,4,5]. During the psychological evaluation, if deemed necessary, interviews may be requested with relatives, partners or friends and contact made with transgender associations. We do not believe that psychotherapy is a necessary requirement for the therapeutic process, but rather that it depends on the individual needs.
It is at this stage that the real-life experience (RLE) begins (if it has not yet begun), with the AGT advising about the measures available for better psychosocial adjustment (laser, speech, etc.). The schedule explained to patients can be seen in Table 2 .
Considerations on the diagnostic evaluation phase
In some cases, the diagnosis of transsexualism is clear from the outset, but in others it is very complex, sometimes raising important dilemmas. The diagnosis is performed considering the notion of the process, that is, the course over time [37, 38] . The difficulties in this phase arise from several factors:
(1) The international classifications (DSM-IV and ICD-10) [39, 40] are quite general and have significant shortcomings, and in many cases they appear to be insufficient for the diagnosis of transsexualism or for a differential diagnosis [1, 2, 5, [38] [39] [40] . The recent DSM-V also has the same limitations [41] . (2) For the diagnosis of transsexualism, there are no objective criteria, so diagnosis is based solely on the subjective patient information [25, 37] . (3) Another difficulty in establishing the diagnosis is the great diversity of forms, situations and experiences presented in gender dysphoria. In addition, cultural differences from country to country can alter the behavioral expression of these persons [1, 2] .
The World Professional Association for Transgender Health (WPATH) recommendations about the responsibility of the psychological team are maximum [1, 2] , as a confirmatory diagnosis will affect the whole subsequent process of change in the body and life of the individual. On multiple occasions we have found psychologically complex persons who have developed coping skills, 22, 27, 28, 42] , are psychotic disorders, personality disorders, transvestism and ego-dystonic homosexuality; these cases are referred to other mental health specialists. However, this situation of exclusion is not always definitive and accepted by patients because the process of sexual identity and the healthcare demands change over time, or are not always well defined.
The AGT members themselves continually reflect on current clinical protocols based on the assumption of a gender binarism that does not correspond to the plurality of gender variants present in real life and in our current clinical practice [6] .
General considerations on cross-sex hormone treatment
For the hormone treatment, the AGT also follows the WPATH recommendations [1, 2, 24, 35, 36] . Although this treatment should be preceded by the RLE, this is not always possible in the social and labor setting of the patient, so these recommendations are flexible and need to be adapted case-by-case.
Simultaneously to the psychological evaluation phase, the endocrinologist starts blood screening that includes several biochemical and hematological tests and sex hormone levels. Bone mineral densitometry (BMD) and pelvic ultrasound should also be done. When the transsexuals meet the eligibility criteria for hormone treatment, the second informed consent is signed with the endocrinologist [5,11 & ,34] . Patients are also informed about the clinical effects and the possible side-effects of hormones and that, as in other countries, none of the prescribed sex hormone products are currently licensed for transsexualism in Spain [24] . The option of storage of gametes should also be discussed, but it is not referred to in Spain for now.
The AGT uses mean doses of either oral or transdermal estrogen therapy and cyproterone acetate (50-100 mg/day) as an antiandrogen in MtFs (with no side-effects in over 500 transsexual patients). In FtMs, we prescribe testosterone ester injections, enanthate or cypionate intramuscular every 2-3 weeks or undecanoate 750-1000 mg for 3 months. Transdermal gel or patches (frequently poorly tolerated) may be used, especially after gonadectomy.
During the cross-sex hormone period, several safety parameters are evaluated, paying special attention to cardiovascular risk factors [15, 43, 44] . The AGT has similar results to those of others [12,45 && ,46,47] . We are concerned about the increase in the metabolic syndrome seen in FtMs after 3-5 years of androgen treatment, but, as others, we have found no worsening of the metabolic or cardiovascular prognosis in MtFs [43, 46, 47] (R. Yahyaoui, unpublished doctoral dissertation).
Patients are assessed by the team every 6-9 months at this stage. It requires adequate supervision by the unit coordinator of these simultaneous visits to different specialists.
After at least 1 year of cross-sex hormone treatment, the patient is included on the waiting list for sex reassignment surgery and we provide reports for them to change their identity card.
Surgical phase and postoperative follow-up
Once the transsexual is receiving cross-sex hormone treatment, is at least 18 years of age, and has been following a RLE for at least 12 months, the patient is contacted by the plastic surgeon and gynecologist for inclusion on the list for surgery. During this period, the patient comes at least once a year to the AGT for clinical and psychosocial adaptation.
The highest priority operations performed by the plastic surgery service are mastectomies for FtMs and vaginoplasties in MtFs. The MtFs with cricothyroid cartilage prominence also undergo surgery. Breast augmentation is not covered though over 40% of MtFs; transsexuals have a private mammoplasty during follow-up.
The MtF patients are requested to discontinue estrogen therapy at least 15 days prior to genitoplasty and all patients receive written information on perioperative care.
Fewer than 3% of the MtFs have required coordination with the urologist for feminizing genitoplasty or urethral complications.
After mastectomy, a FtM will be asked whether they require hystero-oophorectomy and later male genitoplasty. The FtMs are aware of the possibility of neourethra complications and the reoperation rate, which in our experience justifies their wish for no further genital surgery [13, 48] .
Patients are informed about the pathological findings of any surgical specimens, though to date we have found no premalignant or neoplastic lesions in excised tissues (personal communication).
The surgery date can be prioritized during the clinical sessions if the situation warrants it (myomas, breast nodules, and family history of gonadal tumors) or can be delayed for unresolved clinical situations (leukemia, kidney transplantation, active HIV infection, unstable diabetes, recent myocardial infarction, etc.).
After surgery, we insist on lifelong clinical management to avoid hormone overdosing or hypogonadism, special metabolic monitoring (including BMD), and evaluation of psychosocial adjustment. Noncompliant cases are advised to have long-term healthcare in their area, though this is not always possible because of the limited experience of health professionals in the care of transsexuals after SRP. Periodic breast and neovaginal examination in MtFs is strongly recommended and metabolic monitoring in FtMs. Hormone dosage after genitoplasty and gonadectomy is decreased to the level that prevents regression of sex characteristics or osteopenia, but we do not believe in hormone adjustment based on gonadotropin levels encountered after gonadectomy because there is no homogeneity in the luteinizing hormone or follicle-stimulating hormone response [14] .
SPECIFIC CONSIDERATIONS FOR CHILDREN AND YOUNG ADULTS
Our unit pays special attention to the diagnostic procedures and treatment of children and adolescents with gender dysphoria. Diagnostic difficulties of prepubertal transsexualism, the possibility of remission, and questions regarding the safety of blocking puberty are all deeply discussed by the AGT members. We mainly provide support during childhood and for teens older than 12 years with gender dysphoria; we generally assume during follow-up that blocking puberty through the administration of LH releasing harmone (LHRH) analogs after reaching Tanner stage 2 is a wise step to confirm the diagnosis, relieve dysphoria, and also avoid the irreversible development of secondary sex characteristics. ], starts steroid administration for the development of puberty at 16 years of age. It is essential that the young individual and their tutors be placed as much as possible in a situation enabling a responsible decision, fully understanding the consequences of cross-sex hormone treatment [42] .
AGT's experience with children and adolescents with gender dysphoria is summarized in Fig. 1 . On occasion we have withheld pharmacologic manipulation from children less than 12 years of age who present with parents requesting early medical intervention, as at this age such treatment is premature. Most of the adolescents came to the unit in advanced pubertal stages, so puberty was only blocked in seven cases. Cross-hormone treatment has been progressively implemented, as has surgery after reaching the legal age (18 years).
COORDINATION REQUIREMENTS WITH ASSOCIATIONS
In recent years, the AGT has been able to confirm the diversity of the applicants regarding gender variants. Likewise, there has been an increase in 141 subjects (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) patients joining social associations, which has led to an increased demand for the therapeutic procedures or timelines not agreed among scientific societies. This, therefore, makes it even more imperative to organize transgender care in specialized multidisciplinary teams. In Spain, most transgender associations advocate comprehensive treatment within the National Health System [5] . However, recently a few groups belonging to the campaign 'Stop Trans Pathologization' defend decentralization of the healthcare [49] [50] [51] . They consider psychological assessment unnecessary and demand the right to modify their bodies without a psychiatric diagnosis. They also state that cross-hormone therapy should be able to be given by any physician, but give no details about how these persons would access reassignment surgery. Internationally, however, other activists consider, as do the professionals of the AGT, that a disease classification is convenient in order to obtain treatment under medical insurance and to ensure the quality of public healthcare [51] .
CONCLUSION
The members of the AGT have confirmed what the scientific literature has been saying for over 20 years: the extraordinary complexity of the problem, concerning not only the differential diagnosis, but also the suitable comprehensive care and coordination of this care. The gender dysphoria population presents a wide range of anthropological and clinical conditions, not all likely to benefit from a medical surgical approach. The AGT has opted for the comprehensive care of transsexuals when they request the SRP, and to give advice and support to persons with other gender variants or transgender status, until these persons define their healthcare requirements and their gender expectations.
